Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1: A Critical Review

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.1, Iss.2, 2002-02, pp. : 117-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucagon-like Peptide 1 (GLP-1): An Intestinal Hormone, Signalling Nutritional Abundance, with an Unusual Therapeutic Potential

By Holst J.J.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 6, 1999-08 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite

Glucagon-Like Peptide 1 and the Cardiovascular System

Current Diabetes Reviews, Vol. 10, Iss. 5, 2014-09 ,pp. : 302-310

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon-like Peptide 2

By Drucker D.J.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 4, 1999-05 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

By Nagell C. F. Wettergren A. Pedersen J. F. Mortensen D. Holst J. J.

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 353-358

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

By Buteau J. El-Assaad W. Rhodes C. Rosenberg L. Joly E. Prentki M.

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 806-815

Springer Publishing Company

Access to resources Recommend Favorite